Johnson & Johnson innovates against cancer with new therapies

by time news

2024-02-02 20:00:00

Johnson & Johnson It is one of the oldest and most renowned pharmaceutical companies in the world. Its foundation occurred in 1890 and since then it has focused on the development of innovations against multiple diseases. At this time one of his priorities is cancer because it is a public health problem that affects millions of people.

According to figures from National Institute of Statistics and Geography (INEGI)up to 8% of Mexicans die from a malignant tumor. In 2020, more than 195 thousand cases and more than 90 thousand deaths related to this disease were recorded.

February anniversaries that all doctors should know: From Rare Diseases to Cancer Day

For this reason, the World Cancer Day acquires increasing relevance. This initiative commemorates the February 4 and focuses on calling to promote various strategies to reduce the global burden of this disease.

What does Johnson & Johnson do against cancer?

One of the great challenges in the control and treatment of cancer is late detection, as a consequence of the lack of a culture of prevention in health. Between 70 and 80% of all types of cancer They are detected in advanced stages, which means a low expectation of recovery for those who suffer from it.

Mexican innovation! UNAM creates treatment that increases the survival of cancer patients

With this in mind, Johnson & Johnson undertakes research, development and collaboration efforts that focus on areas ranging from understanding disease biology and scientific innovation.

“Today we know that access to appropriate therapies from the beginning of the disease can make the difference between a life with constant relapses and a life where the daily routine is affected as little as possible,” said Santiago Posada, Senior Director of Medical and Regulatory Affairs. from J&J Innovative Medicine.

With more than three decades of dedication to research, clinical experience and innovation in oncology, the company focuses on the development of therapies to respond to unmet medical needs in various types of cancer, such as lung, prostate, and multiple myeloma

Johnson & Johnson’s main innovations against cancer

  • In the treatment of prostate cancerwe work to change paradigms with the development of transformational therapies that delay disease progression, maintain quality of life and prolong patients’ survival, giving them the opportunity to live better.
  • Our innovation provides patients with lung cancer with specific mutations the opportunity to enjoy your life more. For many patients with cancers with genetic mutations, it is essential to have a differentiated diagnosis to optimally guide targeted treatment decisions from the initial diagnosis.
  • In recent years the treatment for hematological cancers has changed completely. In Johnson & Johnson We are aware of the potential to transform the experience of people living with these types of cancers and believe that early treatment with the right medication is crucial to improving the outcomes of this disease.

Also read:
Is it true that there are no dark-skinned Mexican medical influencers? Social service in Medicine: This was the terrifying experience of a doctor

#Johnson #Johnson #innovates #cancer #therapies

You may also like

Leave a Comment